Heart Test Laboratories Stock Market Value
| HSCS Stock | USD 3.02 0.00 0.00% |
| Symbol | Heart |
Is there potential for Health Care Equipment & Supplies market expansion? Will Heart introduce new products? Factors like these will boost the valuation of Heart Test. Market participants price Heart higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Heart Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.56) | Revenue Per Share | Quarterly Revenue Growth 6.538 | Return On Assets | Return On Equity |
Understanding Heart Test Laboratories requires distinguishing between market price and book value, where the latter reflects Heart's accounting equity. The concept of intrinsic value - what Heart Test's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Heart Test's price substantially above or below its fundamental value.
Please note, there is a significant difference between Heart Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heart Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Heart Test's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Heart Test 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Heart Test's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Heart Test.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Heart Test on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Heart Test Laboratories or generate 0.0% return on investment in Heart Test over 90 days. Heart Test is related to or competes with PAVmed, STRATA Skin, Matinas BioPharma, Brainstorm Cell, Autonomix Medical, Impact BioMedical, and Mainz Biomed. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices More
Heart Test Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Heart Test's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Heart Test Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.38 | |||
| Information Ratio | 0.0341 | |||
| Maximum Drawdown | 24.61 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 11.07 |
Heart Test Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heart Test's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Heart Test's standard deviation. In reality, there are many statistical measures that can use Heart Test historical prices to predict the future Heart Test's volatility.| Risk Adjusted Performance | 0.046 | |||
| Jensen Alpha | 0.2566 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.0358 | |||
| Treynor Ratio | (4.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heart Test's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heart Test February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.046 | |||
| Market Risk Adjusted Performance | (4.11) | |||
| Mean Deviation | 4.15 | |||
| Semi Deviation | 4.97 | |||
| Downside Deviation | 5.38 | |||
| Coefficient Of Variation | 2153.54 | |||
| Standard Deviation | 5.66 | |||
| Variance | 32.05 | |||
| Information Ratio | 0.0341 | |||
| Jensen Alpha | 0.2566 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.0358 | |||
| Treynor Ratio | (4.12) | |||
| Maximum Drawdown | 24.61 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 11.07 | |||
| Downside Variance | 28.98 | |||
| Semi Variance | 24.68 | |||
| Expected Short fall | (4.99) | |||
| Skewness | 0.0186 | |||
| Kurtosis | 1.46 |
Heart Test Laboratories Backtested Returns
Currently, Heart Test Laboratories is risky. Heart Test Laboratories holds Efficiency (Sharpe) Ratio of 0.0318, which attests that the entity had a 0.0318 % return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for Heart Test Laboratories, which you can use to evaluate the volatility of the firm. Please check out Heart Test's market risk adjusted performance of (4.11), and Risk Adjusted Performance of 0.046 to validate if the risk estimate we provide is consistent with the expected return of 0.19%. Heart Test has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.0614, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Heart Test are expected to decrease at a much lower rate. During the bear market, Heart Test is likely to outperform the market. Heart Test Laboratories right now retains a risk of 5.87%. Please check out Heart Test treynor ratio, and the relationship between the coefficient of variation and semi variance , to decide if Heart Test will be following its current trending patterns.
Auto-correlation | -0.08 |
Very weak reverse predictability
Heart Test Laboratories has very weak reverse predictability. Overlapping area represents the amount of predictability between Heart Test time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Heart Test Laboratories price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Heart Test price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.